PARP-1 Modulates Amyloid Beta Peptide-Induced Neuronal Damage

被引:59
作者
Martire, Sara [1 ]
Fuso, Andrea [2 ]
Rotili, Dante [3 ]
Tempera, Italo [4 ]
Giordano, Cesare [3 ]
De Zottis, Ivana [1 ]
Muzi, Alessia [5 ]
Vernole, Patrizia [6 ]
Graziani, Grazia [5 ]
Lococo, Emanuela [7 ]
Faraldi, Martina [1 ]
Maras, Bruno [1 ]
Scarpa, Sigfrido [8 ]
Mosca, Luciana [1 ]
d'Erme, Maria [1 ,9 ]
机构
[1] Sapienza Univ, Dept Biochem Sci, Rome, Italy
[2] Sapienza Univ, Dept Psychol Sec Neurosci, Rome, Italy
[3] Sapienza Univ, Dept Pharmaceut Studies, Rome, Italy
[4] Temple Univ, Fels Inst Canc Res & Mol Biol, Philadelphia, PA USA
[5] Univ Roma Tor Vergata, Dept Neurosci, Rome, Italy
[6] Univ Roma Tor Vergata, Dept Publ Hlth & Cell Biol, Rome, Italy
[7] Sapienza Univ, Dept Expt Med, Rome, Italy
[8] Sapienza Univ, Dept Surg P Valdoni, Rome, Italy
[9] Sapienza Univ, Fdn Cenci Bolognetti, Inst Pasteur, Rome, Italy
关键词
NF-KAPPA-B; POLY(ADP-RIBOSE) POLYMERASE-1; OXIDATIVE STRESS; A-BETA; DNA-BINDING; SIGNAL-TRANSDUCTION; CELL-DEATH; ACTIVATION; BRAIN; TARGET;
D O I
10.1371/journal.pone.0072169
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Amyloid beta peptide (A beta) causes neurodegeneration by several mechanisms including oxidative stress, which is known to induce DNA damage with the consequent activation of poly (ADP-ribose) polymerase (PARP-1). To elucidate the role of PARP-1 in the neurodegenerative process, SH-SY5Y neuroblastoma cells were treated with A beta(25-35) fragment in the presence or absence of MC2050, a new PARP-1 inhibitor. A beta(25-35) induces an enhancement of PARP activity which is prevented by cell pre-treatment with MC2050. These data were confirmed by measuring PARP-1 activity in CHO cells transfected with amylod precursor protein and in vivo in brains specimens of TgCRND8 transgenic mice overproducing the amyloid peptide. Following A beta(25-35) exposure a significant increase in intracellular ROS was observed. These data were supported by the finding that A beta(25-35) induces DNA damage which in turn activates PARP-1. Challenge with A beta(25-35) is also able to activate NF-kB via PARP-1, as demonstrated by NF-kB impairment upon MC2050 treatment. Moreover, A beta(25-35) via PARP-1 induces a significant increase in the p53 protein level and a parallel decrease in the anti-apoptotic Bcl-2 protein. These overall data support the hypothesis of PARP-1 involvment in cellular responses induced by A beta and hence a possible rationale for the implication of PARP-1 in neurodegeneration is discussed.
引用
收藏
页数:10
相关论文
共 67 条
[1]   The Poly(ADP-ribose) polymerases (PARPs): New roles in intracellular transport [J].
Abd Elmageed, Zakaria Y. ;
Naura, Amarjit S. ;
Errami, Youssef ;
Zerfaoui, Mourad .
CELLULAR SIGNALLING, 2012, 24 (01) :1-8
[2]   Activation of PARP by Oxidative Stress Induced by β-Amyloid: Implications for Alzheimer's Disease [J].
Abeti, Rosella ;
Duchen, Michael R. .
NEUROCHEMICAL RESEARCH, 2012, 37 (11) :2589-2596
[3]   β-amyloid activates PARP causing astrocytic metabolic failure and neuronal death [J].
Abeti, Rosella ;
Abramov, Andrey Y. ;
Duchen, Michael R. .
BRAIN, 2011, 134 :1658-1672
[4]   β-amyloid peptides induce mitochondrial dysfunction and oxidative stress in astrocytes and death of neurons through activation of NADPH oxidase [J].
Abramov, AY ;
Canevari, L ;
Duchen, MR .
JOURNAL OF NEUROSCIENCE, 2004, 24 (02) :565-575
[5]   NAD+ Depletion Is Necessary and Sufficient for Poly(ADP-Ribose) Polymerase-1-Mediated Neuronal Death [J].
Alano, Conrad C. ;
Garnier, Philippe ;
Ying, Weihai ;
Higashi, Youichirou ;
Kauppinen, Tiina M. ;
Swanson, Raymond A. .
JOURNAL OF NEUROSCIENCE, 2010, 30 (08) :2967-2978
[6]  
de la Lastra CA, 2007, CURR PHARM DESIGN, V13, P933
[7]  
Atherton E., 1989, SOLID PHASE PEPTIDE, Vix, P203
[8]   Dramatic aggregation of Alzheimer Aβ by Cu(II) is induced by conditions representing physiological acidosis [J].
Atwood, CS ;
Moir, RD ;
Huang, XD ;
Scarpa, RC ;
Bacarra, NME ;
Romano, DM ;
Hartshorn, MK ;
Tanzi, RE ;
Bush, AI .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (21) :12817-12826
[9]   Neurodegenerative diseases and oxidative stress [J].
Barnham, KJ ;
Masters, CL ;
Bush, AI .
NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (03) :205-214
[10]  
Beneke Sascha, 2012, Frontiers in Genetics, V3, P169, DOI 10.3389/fgene.2012.00169